JP2001511002A5 - - Google Patents

Download PDF

Info

Publication number
JP2001511002A5
JP2001511002A5 JP1998532897A JP53289798A JP2001511002A5 JP 2001511002 A5 JP2001511002 A5 JP 2001511002A5 JP 1998532897 A JP1998532897 A JP 1998532897A JP 53289798 A JP53289798 A JP 53289798A JP 2001511002 A5 JP2001511002 A5 JP 2001511002A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP1998532897A
Other languages
English (en)
Japanese (ja)
Other versions
JP2001511002A (ja
Filing date
Publication date
Priority claimed from US08/791,115 external-priority patent/US6262242B1/en
Application filed filed Critical
Publication of JP2001511002A publication Critical patent/JP2001511002A/ja
Publication of JP2001511002A5 publication Critical patent/JP2001511002A5/ja
Withdrawn legal-status Critical Current

Links

JP53289798A 1997-01-30 1998-01-08 Ts10q23.3と称する腫瘍抑制因子 Withdrawn JP2001511002A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/791,115 1997-01-30
US08/791,115 US6262242B1 (en) 1997-01-30 1997-01-30 Tumor suppressor designated TS10Q23.3
PCT/US1998/000353 WO1998033907A1 (en) 1997-01-30 1998-01-08 A tumor suppressor designated ts10q23.3

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008184139A Division JP4768783B2 (ja) 1997-01-30 2008-07-15 Ts10q23.3と称する腫瘍抑制因子

Publications (2)

Publication Number Publication Date
JP2001511002A JP2001511002A (ja) 2001-08-07
JP2001511002A5 true JP2001511002A5 (https=) 2005-09-08

Family

ID=25152739

Family Applications (5)

Application Number Title Priority Date Filing Date
JP53289798A Withdrawn JP2001511002A (ja) 1997-01-30 1998-01-08 Ts10q23.3と称する腫瘍抑制因子
JP2008184139A Expired - Lifetime JP4768783B2 (ja) 1997-01-30 2008-07-15 Ts10q23.3と称する腫瘍抑制因子
JP2010139230A Expired - Lifetime JP5202583B2 (ja) 1997-01-30 2010-06-18 Ts10q23.3と称する腫瘍抑制因子
JP2013006918A Withdrawn JP2013128485A (ja) 1997-01-30 2013-01-18 Ts10q23.3と称する腫瘍抑制因子
JP2014040353A Withdrawn JP2014155493A (ja) 1997-01-30 2014-03-03 Ts10q23.3と称する腫瘍抑制因子

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2008184139A Expired - Lifetime JP4768783B2 (ja) 1997-01-30 2008-07-15 Ts10q23.3と称する腫瘍抑制因子
JP2010139230A Expired - Lifetime JP5202583B2 (ja) 1997-01-30 2010-06-18 Ts10q23.3と称する腫瘍抑制因子
JP2013006918A Withdrawn JP2013128485A (ja) 1997-01-30 2013-01-18 Ts10q23.3と称する腫瘍抑制因子
JP2014040353A Withdrawn JP2014155493A (ja) 1997-01-30 2014-03-03 Ts10q23.3と称する腫瘍抑制因子

Country Status (14)

Country Link
US (1) US6262242B1 (https=)
EP (2) EP2366712A3 (https=)
JP (5) JP2001511002A (https=)
AR (1) AR011607A1 (https=)
AT (1) ATE499444T1 (https=)
AU (1) AU745296B2 (https=)
CA (1) CA2278849C (https=)
DE (1) DE69842141D1 (https=)
DK (1) DK0972024T4 (https=)
ES (1) ES2361044T5 (https=)
IL (1) IL131168A0 (https=)
PT (1) PT972024E (https=)
WO (1) WO1998033907A1 (https=)
ZA (1) ZA98756B (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6287854B1 (en) 1996-10-22 2001-09-11 Imperial Cancer Research Technology Limited Diagnosis of susceptibility to cancer and treatment thereof
US6482795B1 (en) 1997-01-30 2002-11-19 Myriad Genetics, Inc. Tumor suppressor designated TS10q23.3
CA2280097A1 (en) * 1997-02-07 1998-08-13 The Trustees Of Columbia University In The City Of New York Use of the p-ten suppressor gene in diagnosis and treatment of cancer
US6861256B2 (en) * 1997-05-15 2005-03-01 The General Hospital Corporation Therapeutic and diagnostic tools for impaired glucose tolerance conditions
US6225120B1 (en) 1997-05-15 2001-05-01 The General Hospital Corporation Therapeutic and diagnostic tools for impaired glucose tolerance conditions
AU8479498A (en) * 1997-07-08 1999-02-08 Cold Spring Harbor Laboratory Dual specificity phosphatase and methods of use
WO1999010537A1 (en) * 1997-08-26 1999-03-04 Board Of Regents, The University Of Texas System A tumor suppressor designated ts10q23.3
AU2002226028A1 (en) 2000-11-14 2002-05-27 Board Of Regents, Unversity Of Texas Systems Mutant human factor ix with an increased resistance to inhibition by heparin
WO2003054512A2 (en) * 2001-12-20 2003-07-03 Tularik Inc. Identification of an amplified gene and target for drug intervention
EP1756137A4 (en) * 2003-11-05 2007-10-31 Univ Texas DIAGNOSTIC AND THERAPEUTIC PROCEDURES AND COMPOSITIONS CONCERNING PTEN AND BREAST CANCER
CN103424541B (zh) 2006-05-18 2018-01-30 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
US8768629B2 (en) * 2009-02-11 2014-07-01 Caris Mpi, Inc. Molecular profiling of tumors
US8583380B2 (en) * 2008-09-05 2013-11-12 Aueon, Inc. Methods for stratifying and annotating cancer drug treatment options
WO2011109440A1 (en) 2010-03-01 2011-09-09 Caris Life Sciences Luxembourg Holdings Biomarkers for theranostics
GB2463401B (en) 2008-11-12 2014-01-29 Caris Life Sciences Luxembourg Holdings S A R L Characterizing prostate disorders by analysis of microvesicles
WO2011127219A1 (en) 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings Circulating biomarkers for disease
RU2565550C2 (ru) 2010-09-24 2015-10-20 Те Борд Оф Трастиз Оф Те Лилэнд Стэнфорд Джуниор Юниверсити Прямой захват, амплификация и секвенирование днк-мишени с использованием иммобилизированных праймеров
US9617601B2 (en) 2011-12-30 2017-04-11 Abbott Molecular Inc. Materials and methods for diagnosis, prognosis and assessment of therapeutic/prophylactic treatment of prostate cancer

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196265A (en) 1977-06-15 1980-04-01 The Wistar Institute Method of producing antibodies
US4554101A (en) 1981-01-09 1985-11-19 New York Blood Center, Inc. Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
NZ207394A (en) 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4800159A (en) 1986-02-07 1989-01-24 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
EP0273085A1 (en) 1986-12-29 1988-07-06 IntraCel Corporation A method for internalizing nucleic acids into eukaryotic cells
AU622104B2 (en) 1987-03-11 1992-04-02 Sangtec Molecular Diagnostics Ab Method of assaying of nucleic acids, a reagent combination and kit therefore
FR2616841A1 (fr) 1987-06-17 1988-12-23 Rauner Hans Perfectionnements au systeme de bloquage en position ouverte a levier de serrage pivotant, pour fiches et paumelles de portes et de fenetres
IL86724A (en) 1987-06-19 1995-01-24 Siska Diagnostics Inc Methods and kits for amplification and testing of nucleic acid sequences
AU622426B2 (en) 1987-12-11 1992-04-09 Abbott Laboratories Assay using template-dependent nucleic acid probe reorganization
WO1989006700A1 (en) 1988-01-21 1989-07-27 Genentech, Inc. Amplification and detection of nucleic acid sequences
CA1340807C (en) 1988-02-24 1999-11-02 Lawrence T. Malek Nucleic acid amplification process
US4932207A (en) 1988-12-28 1990-06-12 Sundstrand Corporation Segmented seal plate for a turbine engine
US5279721A (en) 1993-04-22 1994-01-18 Peter Schmid Apparatus and method for an automated electrophoresis system
BR9611255A (pt) 1995-10-23 1999-12-28 Imp Cancer Research Thecnology ácido nucleico, processos para determinar a suscetibilidade de um paciente a câncer, para diagnosticar câncer em um paciente, para prever as perspectivas relativas do surgimento particular de um câncer em um paciente, para tratar câncer e para determinar a perda de heterozigosidade em amostra de tecido, sistema para detectar a presença ou ausência de, ou mutação, na região de cromossomo 10 humano, polipeptídeo, molécula e uso de ácido nucleico e de uma molécula.
WO1999010537A1 (en) * 1997-08-26 1999-03-04 Board Of Regents, The University Of Texas System A tumor suppressor designated ts10q23.3
US8312249B1 (en) 2008-10-10 2012-11-13 Apple Inc. Dynamic trampoline and structured code generation in a signed code environment
FR2957821B1 (fr) 2010-03-24 2014-08-29 Inst Francais Du Petrole Nouvelle zone de regeneration du catalyseur divisee en secteurs pour unites catalytiques regeneratives

Similar Documents

Publication Publication Date Title
JP2000507042A5 (https=)
JP2000509942A5 (https=)
JP2000509912A5 (https=)
JP2000509637A5 (https=)
JP2000509635A5 (https=)
JP2000509587A5 (https=)
JP2000507369A5 (https=)
JP2000507433A5 (https=)
JP2000508866A5 (https=)
JP2000508022A5 (https=)
JP2000508841A5 (https=)
JP2001512503A5 (https=)
JP2001511208A5 (https=)
JP2000508680A5 (https=)
JP2000509804A5 (https=)
JP2000509853A5 (https=)
JP2000509755A5 (https=)
JP2000510247A5 (https=)
JP2000508836A5 (https=)
JP2000508102A5 (https=)
JP2000509818A5 (https=)
JP2000509520A5 (https=)
JP2001511002A5 (https=)
JP2000507434A5 (https=)
JP2000508880A5 (https=)